Adenocarcinomas metastatic to the liver: The value of cytokeratins 20 and 7 in the search for unknown primary tumors

Cancer

Volumn 85, Issue 1, 1999, Pages 171-177

  Tot, Tibor ^a  

^a FALUN HOSPITAL   (Sweden)

Author keywords

Adenocarcinoma; Cytokeratin 20; Cytokeratin 7; Liver; Metastasis

Indexed keywords

ANTIBODY; CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ALGORITHM; ARTICLE; CANCER LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR;

ADENOCARCINOMA; ALGORITHMS; COLORECTAL NEOPLASMS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; LIVER NEOPLASMS; MALE; NEOPLASMS, UNKNOWN PRIMARY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 0032920473     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990101)85:1<171::AID-CNCR24>3.0.CO;2-V     Document Type: Article

References (20)

1. Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, 2nd series, fascicle 26. Washington DC: Armed Forces Institute of Pathology, 1989:
2. Hainsworth JD, Greco FA. Treatment of patients with cancer of unknown primary site. N Engl J Med 1993;329:257-63.
3. Nadji M, Tabei SZ, Castro A, Chu TM, Morales AR. Prostatic origin of tumours: an immunohistochemical study. Am J Clin Pathol 1980;73:735-9.
4. De Micco C, Ruf J, Carayon P, Chrestian MA, Henry JF, Toga M. Immunohistochemical study of thyroglobulin in thyroid carcinomas with monoclonal antibodies. Cancer 1987;59: 471-6.
5. Fenoglio CM, Crum CP, Pascal RR, Richart RM. Carcinoembryonic antigen in gynecologic patients. Diagn Gynecol Obstet 1981;3:291-9.
6. Brown RW, Campagna LB, Dunn JK, Cagle PT. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 1997;107:12-9.
7. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
8. Moll R. Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Acta Histochemica 1992; XLI(Suppl):117-27.
9. Czernobilsky B, Moll R, Franke WW, Dallenbach-Hellweg G, Hohlweg-Majert P. Intermediate filaments of normal and neoplastic tissues of the female genital tract with emphasis on problems of different tumor diagnosis. Pathol Res Pract 1984;179:31-7.
10. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. Am J Pathol 1992;140:427-47.
11. Ramaekers FCS, van Niekerk CC, Poels LG. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-55.
12. Wauters CCAP, Smedts F, Gerrits LGM, Bosman MT, Ramaekers FC. Keratin 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995;26:852-5.
13. Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994;102(6):764-7.
14. Loy TS, Calaluce RD, Keeney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996;9(11): 1040-4.
15. Berezowski K, Stastny JF, Kornstein MJ. Cytokeratin 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1996;9(4):426-9
16. Sack JM, Roberts SA. Cytokeratin 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn Cytopathol 1997;16(2):132-6.
17. Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111:567-80.
18. Ascoli V. Taccogna S. Scalzo CC, Nardi F. Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions. Diagn Cytopathol 1995;12(4):303-8.
19. Maeda T, Adachi E, Kajiyama K, Ssugimachi K, Tsuneyashi M. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 1995;26:959-64.
20. Ma CK, Zarbo RJ, Frierson HF, Lee MW. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 1993;99: 551-7.